This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
L01XX Other antineoplastic agents
RX_L01XX
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
2195 |
4. Check minimum number of events
Min. number of events
3
|
2195 |
5. Include endpointsNone |
2195 |
6. Filter based on genotype QC (FinnGen only) |
2123 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF3
L01XX Other antineoplastic agents
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2123 | 1039 | 1084 |
| Unadjusted period prevalence (%) | 0.43 | 0.37 | 0.50 |
| Median age at first event (years) | 68.33 | 67.28 | 69.34 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2195
- Matched controls
- 21950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
694.3
311.9
301
5
L01XX11
ATC
estramustine; systemic
164.4
309.3
153
10
L03AB05
ATC
interferon alfa-2b; parenteral
110.6
307.7
192
19
D75.2
ICD-10 Finland
Essential thrombocytosis
456.3
307.7
645
20
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
811.3
307.7
906
19
TPH00
NOMESCO Finland
Phlebotomy
227.0
307.7
295
15
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
239.1
307.7
235
11
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
36.3
307.7
260
81
XW000
NOMESCO Finland
Bone marrow biopsy
22.8
307.7
749
487
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
2224.6
307.7
355
*
D45
ICD-10 Finland
Polycythaemia vera
387.8
307.7
761
30
SPAT1074
SPAT
Venesection
108.2
307.7
215
22
L01XX05
ATC
hydroxycarbamide; oral
5261.8
307.7
1662
13
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
271.8
307.7
1863
444
L01XX35
ATC
anagrelide; oral
+∞
267.3
251
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
54.7
259.9
148
29
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
20.9
246.8
190
99
B99
ICPC
Blood/lymph/spleen disease other
51.8
220.7
127
26
M04AA01
ATC
allopurinol; systemic
4.1
190.7
698
2236
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
24.9
181.3
129
55
L01XX52
ATC
venetoclax; oral
889.9
170.3
165
*
399
Kela drug reimbursment
Venetoclax
413.5
156.4
155
*
1518, ,
Kela drug reimbursment
376.0
142.6
142
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
129.5
540
1839
212
Kela drug reimbursment
Gout
8.1
120.9
168
222
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
30.7
116.9
77
26
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
44.6
109.4
65
15
B74
ICPC
Malignant neoplasm blood other
61.7
107.7
60
10
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
24.2
104.9
75
32
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
276.0
103.8
105
*
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
1046.0
103.1
100
*
189
Kela drug reimbursment
Imatinib
41.8
101.0
61
15
L03AB04
ATC
interferon alfa-2a; parenteral
181.8
100.2
104
6
WW500
NOMESCO Finland
Blood transfusion
5.2
99.6
218
455
L03AA02
ATC
filgrastim; parenteral
5.9
95.8
181
330
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
27.9
95.7
65
24
174
Kela drug reimbursment
Ruxolitinib
472.0
92.0
91
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
14.1
89.8
83
61
374
Kela drug reimbursment
Ruxolitinib
423.1
82.5
82
*
L01EJ01
ATC
ruxolitinib; oral
396.0
77.3
77
*
L01XE01
ATC
[U] imatinib
40.0
76.9
47
12
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
24.7
74.7
53
22
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
7.5
68.9
100
138
A04AA01
ATC
ondansetron; systemic, rectal
3.2
66.9
296
1018
B28
ICPC
Limited function/disability (B)
16.4
66.0
56
35
B03XA02
ATC
darbepoetin alfa; parenteral
5.4
62.5
126
243
L01XX28
ATC
[U] imatinib
+∞
60.7
58
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
57.5
307
1170
TPH00, ,
SPAT
106.3
57.1
62
6
L03AA04, ,
ATC
23.9
55.7
40
17
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.0
53.3
117
243
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
12.0
52.4
53
45
390
Kela drug reimbursment
Ibrutinib
67.8
46.3
53
8
L01XE18
ATC
[U] ruxolitinib
240.0
46.2
47
*
1512
Kela drug reimbursment
Ibrutinib
76.2
46.1
52
7
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
10.9
44.5
48
45
L01XE27
ATC
[U] ibrutinib
142.7
39.9
42
*
B03XA01
ATC
erythropoietin; parenteral
7.5
39.1
56
76
372
Kela drug reimbursment
Idelalisib
383.9
38.1
38
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
15.2
37.4
33
22
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
99.3
35.8
39
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
13.3
35.7
34
26
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
35.6
180
661
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
12.2
35.1
35
29
L01XX47
ATC
[U] idelalisib
342.3
34.0
34
*
116
Kela drug reimbursment
Prostate cancer
2.5
33.7
220
919
ZX120
NOMESCO Finland
Intravenous
2.3
33.6
277
1287
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
32.1
341
1753
R50.9
ICD-10 Finland
Fever, unspecified
2.0
31.8
378
2027
L01XX23
ATC
mitotane; oral
+∞
31.3
30
*
B04
ICPC
Blood symptom/complaint
8.3
31.3
41
50
C90.0
ICD-10 Finland
Multiple myeloma
5.4
31.1
62
118
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
31.1
230
1018
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
31.0
1155
8715
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
317.3
30.9
31
*
L01XX54
ATC
[U] niraparib
+∞
30.3
29
*
L01XX46
ATC
[U] olaparib
+∞
30.3
29
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.2
30.2
63
125
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
29.8
186
760
7512
FHL
Orchidectomy (bilateral)
35.1
29.7
38
11
B01AB05
ATC
enoxaparin; parenteral
1.7
29.5
791
5448
L01BB05
ATC
fludarabine; systemic
50.8
29.4
35
7
B01AC14
ATC
[U] anagrelide
+∞
29.2
28
*
L01XX50
ATC
[U] ixazomib
295.8
28.8
29
*
1511
Kela drug reimbursment
Olaparib
81.2
28.8
32
*
389
Kela drug reimbursment
Olaparib
78.7
27.8
31
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
6.5
27.8
45
70
D75.1
ICD-10 Finland
Secondary polycythaemia
8.7
27.5
35
41
H02AB09
ATC
hydrocortisone; systemic
4.0
27.4
78
199
1505
Kela drug reimbursment
Ixazomib
98.0
26.7
29
*
398
Kela drug reimbursment
Ixazomib
73.6
25.8
29
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.9
25.5
127
462
3009
Kela drug reimbursment
Niraparib
39.3
24.9
31
8
1510
Kela drug reimbursment
Niraparib
39.3
24.9
31
8
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
7.3
24.6
36
50
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
22.2
24.3
35
16
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
68.2
23.8
27
*
L02BB03
ATC
bicalutamide; oral
3.0
23.8
111
389
B73
ICPC
Leukaemia
30.4
22.8
30
10
L01AB01
ATC
busulfan; systemic
232.3
22.7
23
*
ZX112
NOMESCO Finland
Subcutaneous
3.5
22.6
77
223
B01AB10
ATC
tinzaparin; parenteral
2.0
22.4
260
1372
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.7
21.8
122
472
JN4AD
NOMESCO Finland
Body CT examination
1.9
21.2
273
1493
L01EA01
ATC
imatinib; oral
34.1
21.1
27
8
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
24.5
20.8
29
12
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
20.3
20.4
30
15
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
20.0
250
1352
L01XK01
ATC
olaparib; oral
58.1
19.9
23
*
316
Kela drug reimbursment
Imatinib
40.5
19.5
24
6
D75.0
ICD-10 Finland
Familial erythrocytosis
40.5
19.5
24
6
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
19.2
285
1631
G03HA01
ATC
cyproterone; systemic
5.4
19.0
37
69
WW200
NOMESCO Finland
Immunization
3.3
18.4
71
223
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.4
18.2
126
539
L01EL01
ATC
ibrutinib; oral
44.4
18.2
22
5
S97
ICPC
Chronic ulcer skin
2.1
18.2
178
880
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
5.4
17.8
35
66
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.3
17.6
137
618
L01XX17
ATC
[U] topotecan
95.8
17.6
19
*
8370/3-C74.0
ICD-O-3
Adrenal cortical carcinoma of cortex of adrenal gland
181.4
17.5
18
*
J05AB11
ATC
valaciclovir; oral
1.8
17.4
308
1855
L02BB01
ATC
flutamide; oral
12.7
17.1
30
24
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.9
17.0
81
288
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
6.1
16.9
29
48
D73.5
ICD-10 Finland
Infarction of spleen
22.0
16.9
24
11
L02AE03
ATC
goserelin; implant
4.1
16.6
45
111
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.3
16.6
33
63
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.2
16.6
44
107
L04AX04
ATC
lenalidomide; oral
5.6
16.5
31
56
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
16.5
481
3298
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.3
16.5
62
192
L03AA13
ATC
pegfilgrastim; parenteral
2.4
16.4
115
496
128
Kela drug reimbursment
Cancers of female genital organs
3.3
16.0
59
180
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
24.7
16.0
22
9
153
Kela drug reimbursment
Lenalidomid
5.4
15.9
31
58
A05AA02
ATC
ursodeoxycholic acid; oral
4.2
15.8
42
102
KFC10
NOMESCO Finland
Bilateral orchiectomy
6.9
15.7
24
35
L01XK02
ATC
niraparib; oral
26.5
15.6
21
8
B75
ICPC
Neoplasm blood benign/unspecified
161.1
15.5
16
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
15.3
148
728
J02AC03
ATC
voriconazole; systemic
17.9
15.1
23
13
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.7
15.1
48
133
JN6AD
NOMESCO Finland
CT of torso and neck
3.6
15.0
50
143
I81
ICD-10 Finland
Portal vein thrombosis
6.8
14.9
23
34
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.7
14.6
264
1597
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
+∞
14.6
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.8
14.5
250
1491
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
36.3
14.4
18
5
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
14.4
149
752
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
3.2
14.2
57
184
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.9
14.1
41
107
ZX108
NOMESCO Finland
Inhalation
5.5
14.0
27
50
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
30.2
13.9
18
6
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.9
13.6
40
105
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.7
13.6
70
260
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
34.2
13.5
17
5
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
12.9
13.4
23
18
L57.0
ICD-10 Finland
Actinic keratosis
1.7
13.4
283
1786
JN4BD
NOMESCO Finland
Extensive body CT
1.7
13.2
259
1602
Z3231
NOMESCO Finland
Registered nurse
1.5
13.0
578
4308
Z51.5
ICD-10 Finland
Palliative care
1.8
13.0
213
1253
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
5.6
12.9
24
43
N02AA05
ATC
oxycodone; systemic
1.5
12.8
441
3118
XQ848
NOMESCO Finland
Dermatological photography
2.6
12.8
76
304
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.7
12.7
39
106
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
12.7
132
669
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
12.6
171
948
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
12.3
12.6
22
18
XW000, ,
SPAT
32.2
12.6
16
5
1507
Kela drug reimbursment
Pomalidomide
11.1
12.5
23
21
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
17.4
12.5
19
11
C03CA01
ATC
furosemide; systemic
1.4
12.5
778
6155
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.8
12.4
62
227
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.0
12.4
53
178
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
12.3
704
5484
393
Kela drug reimbursment
Pomalidomide
9.7
12.2
24
25
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.6
12.2
69
269
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
12.2
205
1213
1XC02, ,
NOMESCO Finland
4.6
12.1
28
61
A10BA02
ATC
metformin; oral
0.7
12.1
362
5097
L01AA02
ATC
chlorambucil; oral
8.7
12.0
25
29
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
12.0
238
1475
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
4.2
12.0
31
74
TQW99
NOMESCO Finland
Other minor procedure on skin
2.0
12.0
135
704
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.4
11.8
82
353
L04AX06
ATC
pomalidomide; oral
9.7
11.7
23
24
103
Kela drug reimbursment
Diabetes, insulin-treated
0.6
11.7
338
4802
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
11.7
650
5031
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.4
11.5
40
118
D06BB10
ATC
imiquimod; topical
2.0
11.4
117
589
R04.0
ICD-10 Finland
Epistaxis
1.8
11.3
188
1108
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
11.3
541
4073
ZYC01
NOMESCO Finland
Remote contact by phone
2.0
11.2
115
580
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
11.0
220
1366
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.6
10.8
60
232
C83.00
ICD-10 Finland
Lymphocytic lymphoma
9.6
10.7
21
22
7461
FHL
Needle biopsy in the operating room
10.1
10.5
20
20
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
110.5
10.4
11
*
L01EL02
ATC
acalabrutinib; oral
110.5
10.4
11
*
L01EM01
ATC
idelalisib; oral
+∞
10.4
10
*
SPAT1088
SPAT
Blood transfusion
4.7
10.2
23
49
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
23.5
10.2
14
6
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
10.1
463
3450
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.4
10.0
35
104
J01MA12
ATC
levofloxacin; systemic
1.5
10.0
408
2972
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
40.2
10.0
12
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
16.8
9.9
15
9
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.4
9.9
35
105
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
9.6
297
2045
Z2221
NOMESCO Finland
Medical doctor
1.4
9.5
523
4016
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
9.5
453
3395
L01AA04, ,
ATC
100.5
9.4
10
*
PH_2
NOMESCO Finland
Other procedures on veins
+∞
9.4
9
*
J01DB01
ATC
cefalexin; oral
1.4
9.4
1649
15068
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
9.2
491
3749
TGC00
NOMESCO Finland
Bronchial lavation
2.4
9.1
63
272
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
4.8
9.1
20
42
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.2
9.1
71
323
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
24.1
8.9
12
5
L01AA01
ATC
cyclophosphamide; systemic
4.9
8.8
19
39
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
10.7
8.8
16
15
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
7.2
8.7
20
28
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.2
8.7
68
309
C56
ICD-10 Finland
Malignant neoplasm of ovary
4.3
8.7
22
52
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
4.3
8.7
22
52
K93
ICPC
Pulmonary embolism
3.5
8.6
29
84
T90
ICPC
Diabetes non-insulin dependent
0.7
8.6
305
4199
B01AB04
ATC
dalteparin; parenteral
1.9
8.6
110
599
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.0
8.6
87
437
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.6
742
6097
WW409
NOMESCO Finland
Other aferesis
11.6
8.6
15
13
L71.9
ICD-10 Finland
Rosacea, unspecified
2.4
8.5
55
230
S91.0
ICD-10 Finland
Open wound of ankle
3.4
8.5
29
85
JAL30
NOMESCO Finland
Omentectomy
3.2
8.5
32
100
150
Kela drug reimbursment
Dasatinib
90.4
8.4
9
*
1532, ,
Kela drug reimbursment
90.4
8.4
9
*
3059, ,
Kela drug reimbursment
90.4
8.4
9
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
90.4
8.4
9
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
6.7
8.4
20
30
N02AX02
ATC
tramadol; systemic, rectal
1.3
8.3
891
7536
H02AA02
ATC
fludrocortisone; oral
3.6
8.3
26
72
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
8.2
304
4152
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
33.5
8.1
10
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
22.1
8.0
11
5
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
8.0
234
3344
ZZR00
NOMESCO Finland
Flap of skin
2.2
7.9
61
276
ZY010
NOMESCO Finland
Hospital outpatient
2.1
7.8
75
370
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.6
7.8
166
2544
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.8
7.8
23
61
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
45.1
7.7
9
*
D47
ICD-10 Finland
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
45.1
7.7
9
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
2.7
7.7
40
151
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
4.0
7.6
21
53
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
25.1
7.6
10
*
TQW80
NOMESCO Finland
Local dermatologic skincare
2.2
7.6
60
275
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.9
7.5
86
453
L01XE06
ATC
[U] dasatinib
80.4
7.4
8
*
D57.1
ICD-10 Finland
Sickle-cell anaemia without crisis
+∞
7.3
7
*
V04CD01
ATC
metyrapone; oral
+∞
7.3
7
*
A02BC02
ATC
pantoprazole; systemic
1.3
7.2
1406
12742
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.1
7.2
64
307
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
4.3
7.2
18
42
L03AA14
ATC
lipegfilgrastim; parenteral
2.5
7.2
42
168
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.9
7.2
20
51
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
30.1
7.1
9
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
7.1
347
2599
L02AA02
ATC
polyestradiol phosphate; parenteral
20.1
7.1
10
5
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
7.1
199
1339
R51.80
ICD-10 Finland
Headache
1.5
7.0
245
1726
6BA02, ,
NOMESCO Finland
10.1
7.0
13
13
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.9
7.0
31
107
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
4.2
7.0
18
43
A41.9
ICD-10 Finland
Sepsis, unspecified
1.9
7.0
82
436
H02AB02
ATC
dexamethasone; systemic
1.5
6.9
234
1638
1XC07, ,
NOMESCO Finland
7.5
6.9
15
20
D73.1
ICD-10 Finland
Hypersplenism
13.8
6.9
11
8
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
3.2
6.8
26
82
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
2.5
6.8
40
161
WW300
NOMESCO Finland
Transfer of autologic stem cells
6.4
6.6
16
25
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.7
6.6
336
4370
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.9
6.6
79
423
329
Kela drug reimbursment
Lenalidomide
4.2
6.5
17
41
NHQ40
NOMESCO Finland
Amputation of toe
2.5
6.4
39
159
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
70.1
6.4
7
*
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.8
6.4
30
107
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
6.4
228
1613
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
14.3
6.4
10
7
N05CF01
ATC
zopiclone; oral
1.3
6.4
661
5520
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.7
6.4
102
598
A10BB12
ATC
glimepiride; oral
0.5
6.3
59
1132
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.3
251
1812
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
6.6
6.3
15
23
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
6.6
6.3
15
23
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
2.9
6.3
28
97
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
5.5
6.3
17
31
127
Kela drug reimbursment
Transplant complication
2.8
6.3
29
103
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
18.1
6.3
9
5
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
26.7
6.2
8
*
A10BK03
ATC
empagliflozin; oral
0.6
6.2
81
1405
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.1
6.2
55
265
AA1AD
NOMESCO Finland
CT of head and brain
1.3
6.2
595
4919
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
1.9
6.1
72
384
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
6.1
223
1588
D69.5
ICD-10 Finland
Secondary thrombocytopenia
6.7
6.0
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
670
1405
6.42
322.01
12.0
3.6
0.73
0.68
%
0.22
408
485
1793
8613
6.91
319.65
20.8
5.9
26.43
26.64
%
0.26
1753
8027
1829
8959
7.25
318.11
17.8
5.5
0.64
0.61
e9/l
0.91
1703
7628
1774
8469
6.71
317.77
18.8
5.7
59.49
57.98
%
4.30
1732
7885
1830
8977
7.25
317.46
17.8
5.5
0.07
0.04
e9/l
42.76
1706
7646
1837
9154
7.17
309.32
18.1
5.6
2.66
1.89
e9/l
2.83
1736
7983
1847
9265
7.27
308.06
19.9
5.7
0.20
0.19
e9/l
0.29
1726
8016
1385
5004
5.79
307.65
6.9
2.8
931.14
6561.09
umol/l
11.27
1309
4266
1773
8200
7.05
307.65
19.8
5.7
1.00
0.66
%
54.23
1731
7611
601
300
27.21
307.65
1.2
1.2
34.16
50.24
u/l
0.67
488
257
613
325
25.78
307.65
1.6
1.5
—
—
—
0
0
1789
8462
7.02
307.65
21.6
6.0
8.37
8.91
%
8.02
1748
7871
1632
2359
24.07
307.65
12.7
3.6
281.41
247.37
u/l
8.36
1590
2216
1790
8427
7.09
307.65
20.2
5.7
2.36
2.85
%
23.22
1750
7825
972
1834
8.72
307.65
5.4
2.4
76.05
69.33
e9/l
4.89
727
1416
1113
2434
8.25
307.65
5.2
2.4
1.92
1.81
%
2.17
1003
2151
613
157
53.79
307.65
1.0
1.1
—
—
—
0
0
641
1468
5.76
276.57
12.4
3.9
0.16
0.10
%
1.46
371
483
1880
10521
6.48
248.05
29.7
8.7
5.07
4.21
e9/l
10.01
1784
9103
845
2738
4.39
233.36
2.6
2.5
23.34
22.05
%
1.49
733
2340
860
2897
4.24
223.80
2.5
2.5
2.35
2.28
g/l
2.68
825
2679
883
3119
4.06
213.32
2.5
2.5
13.29
12.36
umol/l
2.92
853
2910
313
490
7.28
195.72
3.2
2.3
3.35
3.59
g/l
2.08
299
460
253
335
8.41
183.02
9.3
3.3
1.25
1.46
%
0.45
226
288
429
1018
4.99
171.88
2.2
1.8
1.07
1.55
g/l
21.43
376
875
1670
10047
3.77
160.63
13.1
6.3
11.73
11.89
umol/l
0.21
1636
9532
293
538
6.13
155.65
2.1
1.5
—
—
—
0
0
212
331
6.98
131.62
6.1
5.4
316.90
840.28
iu/ml
0.74
31
53
1283
7186
2.89
127.04
3.8
2.8
171.55
152.44
ug/l
1.16
1203
6497
166
209
8.51
124.38
9.7
3.3
57.75
57.17
%
0.09
136
171
242
503
5.28
111.34
3.0
2.1
93.79
88.38
%
2.98
212
490
1319
7934
2.66
106.33
26.2
10.1
0.06
0.00
e9/l
3.27
1190
6413
61
17
36.88
97.82
1.0
1.0
—
—
—
0
0
159
261
6.49
93.58
2.4
2.4
207.18
1212.45
u/ml
0.74
11
20
182
358
5.45
88.66
6.4
3.3
61.15
58.14
%
1.55
182
358
1492
10001
2.54
88.45
11.8
6.9
1.21
1.21
mmol/l
0.03
1282
8438
121
164
7.75
84.87
2.1
2.0
3.53
4.24
mg/l
1.47
121
158
375
1318
3.23
82.60
5.2
2.7
9.10
10.67
g/l
5.59
354
1190
594
2700
2.65
81.24
7.4
5.4
1.09
1.03
mmol/l
6.48
568
2473
97
113
8.93
77.00
2.1
1.4
—
—
—
0
0
97
113
8.93
77.00
2.1
1.4
—
—
—
0
0
902
5073
2.32
76.39
2.5
2.2
5.05
3.06
mg/l
17.23
790
4284
1368
9163
2.31
75.80
9.8
6.0
1.22
1.21
mmol/l
4.13
1268
8276
1866
14465
2.93
73.47
20.1
7.7
83.69
79.90
u/l
3.19
1828
13570
189
462
4.38
70.72
3.6
2.3
181.26
202.65
%
2.41
182
440
865
4982
2.22
67.08
1.9
1.6
20.68
20.42
nmol/l
0.18
784
4164
624
3254
2.28
60.58
4.4
3.2
0.83
0.82
mmol/l
1.80
597
3034
808
4761
2.10
56.95
6.1
4.0
84.27
86.42
%
1.56
763
4650
412
1845
2.52
55.96
4.4
2.7
65.25
66.40
g/l
2.08
381
1683
587
3103
2.22
54.27
3.0
2.0
31.37
29.97
s
4.53
551
3009
52
41
12.97
53.84
1.2
1.3
—
—
—
0
0
1211
8411
1.98
52.47
2.4
2.1
90.42
94.14
pmol/l
2.11
773
4268
438
2101
2.36
50.68
5.4
2.7
6.84
9.25
umol/l
2.06
401
1852
72
101
7.34
48.85
2.9
2.7
31.15
41.46
%
1.92
27
62
161
471
3.61
46.59
2.9
1.5
—
—
—
0
0
54
9
61.46
46.48
4.2
5.2
—
—
—
0
0
50
5
102.32
45.95
1.4
1.0
—
—
—
0
0
157
457
3.62
45.77
3.1
1.5
—
—
—
0
0
160
475
3.55
45.27
3.5
2.9
1.37
1.69
mg/l
5.49
152
427
260
1053
2.67
42.80
2.1
1.9
1.12
1.56
g/l
2.51
224
945
1471
11359
1.89
41.66
6.4
4.9
6.52
6.86
mmol/l
11.37
1430
10728
119
310
4.00
40.64
3.3
1.4
—
—
—
0
0
119
310
4.00
40.64
3.3
1.4
—
—
—
0
0
109
271
4.18
39.65
1.2
1.2
—
—
—
0
0
1185
8637
1.81
39.57
7.6
4.7
35.18
34.81
g/l
1.43
1124
8015
63
101
6.39
37.75
5.8
3.7
—
—
—
0
0
634
3867
1.90
37.32
2.5
1.6
1.31
1.45
mg/l
0.55
503
3026
120
346
3.61
35.41
3.1
1.6
—
—
—
0
0
187
711
2.78
34.61
6.8
3.4
5.69
1.82
ratio
0.41
18
53
56
87
6.58
34.58
3.3
1.8
0.23
0.23
e9/l
0.03
47
77
572
3447
1.89
34.52
2.8
1.8
—
—
—
0
0
190
734
2.74
34.10
7.3
3.4
43.46
56.63
mg/l
0.77
171
605
38
5
77.43
33.91
8.3
11.8
—
—
—
0
0
56
89
6.43
33.84
3.2
1.8
1375.18
567.00
e6/l
0.59
44
77
189
735
2.72
33.48
7.3
3.4
44.29
77.64
mg/l
0.89
171
607
211
872
2.57
33.07
3.5
2.4
3.18
3.70
g/l
7.08
194
789
211
873
2.57
32.99
3.5
2.4
—
—
—
0
0
211
873
2.57
32.99
3.5
2.4
6.72
7.45
g/l
10.35
195
789
200
812
2.61
32.50
3.5
2.5
2.96
3.00
g/l
0.30
183
729
97
261
3.84
31.65
1.3
1.3
111.13
126.70
u/ml
0.38
16
46
172
658
2.75
31.41
3.4
2.4
0.00
0.02
g/l
1.06
157
606
187
747
2.64
31.37
4.0
2.6
1.42
1.12
g/l
0.35
167
649
198
821
2.55
30.77
3.6
2.5
10.32
10.42
g/l
0.09
180
731
58
105
5.65
30.73
2.0
1.9
15.38
16.78
%
0.31
53
98
57
104
5.60
29.96
2.0
2.0
—
—
—
0
0
44
62
7.22
29.71
1.7
2.4
291.67
39899.25
u/ml
—
6
12
93
256
3.75
29.37
1.2
1.2
348.52
285.46
u/ml
0.59
46
149
63
131
4.92
28.63
1.4
1.3
—
—
—
0
0
106
329
3.33
27.90
1.8
1.4
—
—
—
0
0
157
623
2.64
26.64
3.4
2.4
0.00
0.00
g/l
-0.00
143
574
620
4102
1.71
26.16
1.8
1.8
1080.69
1170.22
nmol/l
1.68
464
3069
167
692
2.53
25.92
3.3
2.3
38.90
37.44
g/l
2.37
151
608
154
616
2.61
25.70
3.4
2.4
0.00
0.00
g/l
-0.00
143
573
89
263
3.48
25.31
1.7
1.4
—
—
—
0
0
1601
13501
1.69
25.19
5.7
4.2
13.05
13.88
mm/h
1.12
1501
12387
280
1471
2.04
24.54
2.2
1.6
—
—
—
0
0
61
142
4.39
24.19
1.8
1.6
—
—
—
0
0
73
195
3.84
24.09
4.1
1.4
—
—
—
0
0
109
378
2.98
23.83
1.2
1.3
—
—
—
0
0
75
209
3.68
23.29
4.0
1.4
—
—
—
0
0
400
2417
1.80
22.82
2.3
1.8
—
—
—
0
0
43
79
5.53
22.45
5.5
1.4
—
—
—
0
0
43
79
5.53
22.45
5.5
1.4
—
—
—
0
0
43
80
5.46
22.16
5.5
1.4
—
—
—
0
0
395
2402
1.79
21.99
2.3
1.8
—
—
—
0
0
47
100
4.78
20.83
5.1
1.4
—
—
—
0
0
47
100
4.78
20.83
5.1
1.4
—
—
—
0
0
31
44
7.13
20.79
4.1
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
166
758
2.29
20.72
3.5
2.7
0.33
0.35
u/ml
0.35
107
445
72
212
3.48
20.62
2.0
1.4
—
—
—
0
0
72
212
3.48
20.62
2.0
1.4
—
—
—
0
0
74
222
3.41
20.59
1.7
1.7
—
—
—
0
0
87
291
3.07
20.27
2.0
1.4
—
—
—
0
0
1200
9728
1.52
19.72
20.1
17.7
1.37
1.33
inr
0.64
385
2753
294
1688
1.86
19.61
4.5
4.0
1.22
1.22
mmol/l
1.93
259
1464
40
78
5.20
19.59
1.2
1.2
—
—
—
0
0
61
169
3.68
19.14
4.4
1.3
—
—
—
0
0
61
169
3.68
19.14
4.4
1.3
—
—
—
0
0
61
169
3.68
19.14
4.4
1.3
—
—
—
0
0
26
34
7.73
18.70
1.2
1.0
—
—
—
0
0
34
60
5.74
18.53
1.5
1.4
—
—
—
0
0
77
253
3.12
18.51
1.9
1.4
—
—
—
0
0
27
38
7.18
18.24
1.5
1.3
—
—
—
0
0
68
212
3.28
17.83
3.1
2.8
—
—
—
0
0
1080
8753
1.46
16.56
5.1
2.7
—
—
—
0
0
78
277
2.88
16.39
1.8
1.6
—
—
—
0
0
234
1325
1.86
16.20
2.0
1.7
—
—
—
0
0
744
5651
1.48
15.71
5.6
3.2
30.85
35.07
u/l
1.46
712
5362
445
3044
1.58
15.28
2.2
1.5
1.99
2.64
g/l
8.38
285
1748
170
894
1.98
14.69
2.5
1.9
1.49
2.40
ug/l
0.61
153
783
132
641
2.13
14.16
1.6
1.2
—
—
—
0
0
29
57
5.14
14.11
1.1
1.2
—
—
—
0
0
629
4710
1.47
13.94
5.2
2.4
—
—
—
0
0
59
197
3.05
13.86
1.0
1.1
—
—
—
0
0
825
6513
1.43
13.74
3.4
3.1
2087.92
1559.56
ng/l
1.21
732
5639
263
1620
1.71
13.61
3.3
2.2
413.04
370.89
nmol/l
2.17
244
1467
297
1896
1.66
13.42
5.8
6.7
10.22
10.51
mmol/l
0.29
278
1797
61
212
2.93
13.38
1.1
1.2
2.11
4.43
u/ml
0.75
27
65
27
53
5.15
13.16
1.6
2.0
—
—
—
0
0
24
44
5.50
12.59
1.7
1.3
—
—
—
0
0
56
193
2.95
12.48
1.0
1.1
113.96
115.09
%
0.11
51
175
32
77
4.20
12.25
2.3
2.6
2163.06
1459.26
u/ml
0.62
32
77
1901
17610
1.59
12.24
33.8
16.4
21.04
26.10
mg/l
10.83
1664
14246
1647
14828
1.44
12.07
45.9
19.4
16.52
15.37
%
15.16
1642
14527
22
39
5.69
11.95
1.3
1.1
68.36
85.65
%
1.25
11
23
40
119
3.41
11.38
1.3
1.2
—
—
—
0
0
21
39
5.43
10.87
1.3
1.5
77.82
83.87
%
0.24
11
24
22
43
5.16
10.79
2.3
2.0
29.94
28.53
%
0.11
17
36
1045
8818
1.35
10.78
5.2
5.3
0.00
0.00
estimate
-0.00
276
1674
832
6803
1.36
10.43
3.9
3.4
2.33
2.36
mmol/l
4.63
739
5878
693
5505
1.38
10.43
3.5
3.3
0.53
0.49
e6/l
0.13
547
4274
54
202
2.72
10.41
1.1
1.2
4.36
4.87
u/ml
0.07
22
89
1053
8931
1.34
10.34
4.0
4.0
0.00
0.01
estimate
1.08
283
1621
19
19
10.08
10.01
1.3
1.2
77.50
78.71
%
—
8
7
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
19
19
10.08
10.01
1.3
1.1
76.75
73.83
%
—
8
6
54
207
2.65
9.94
1.3
1.4
250.55
325.55
pmol/l
0.82
42
182
740
5982
1.36
9.85
3.5
3.4
61.58
83.80
e6/l
0.37
588
4681
827
6832
1.34
9.43
4.1
3.9
125.02
121.06
e6/l
0.04
616
5008
1033
8827
1.32
9.25
4.0
4.0
0.00
0.00
estimate
1.23
295
1811
32
96
3.37
9.04
2.5
1.3
—
—
—
0
0
32
96
3.37
9.04
2.5
1.3
—
—
—
0
0
514
3967
1.39
9.01
4.2
4.0
599.16
613.98
ng/l
0.01
435
3367
131
745
1.81
8.95
3.5
2.6
—
—
—
0
0
39
133
2.97
8.94
2.2
1.3
—
—
—
0
0
147
873
1.73
8.66
4.0
1.9
—
—
—
0
0
42
152
2.80
8.66
1.1
1.0
—
—
—
0
0
138
806
1.76
8.62
2.4
1.8
—
—
—
0
0
13
8
16.34
8.55
2.1
1.9
1.58
2.00
%
—
13
8
90
461
1.99
8.46
1.3
1.6
0.22
0.24
g/l
0.77
82
440
91
471
1.97
8.31
1.4
1.5
—
—
—
0
0
92
478
1.97
8.31
1.3
1.5
1.11
1.19
g/l
1.72
85
456
89
460
1.97
8.17
1.9
2.0
17.85
12.19
mg/l
1.42
78
419
19
42
4.55
8.12
1.8
1.7
299.08
237.33
nmol/24h
0.12
19
42
721
5943
1.32
8.03
3.1
2.6
52.28
73.45
u/l
0.92
665
5461
30
94
3.22
7.94
1.2
1.1
—
—
—
0
0
43
166
2.62
7.87
1.8
1.6
—
—
—
0
0
907
7730
1.30
7.84
4.2
4.0
41.43
118.31
ng/l
0.79
745
5890
37
133
2.81
7.76
2.3
1.3
—
—
—
0
0
66
317
2.12
7.41
1.3
1.3
—
—
—
0
0
532
4244
1.33
7.34
2.8
2.6
4.59
5.17
e6/l
0.61
497
3825
1374
12406
1.29
7.33
5.2
4.9
6449.11
1575.09
e6/l
—
9
206
13
12
10.89
7.29
1.3
1.4
—
—
—
0
0
16
24
6.71
6.81
1.6
1.8
—
—
—
0
0
57
268
2.16
6.79
6.1
6.8
11.84
12.43
mg/l
0.50
51
252
60
289
2.11
6.72
1.4
1.4
2056.50
1670.94
e6/l
0.33
42
209
188
1268
1.53
6.67
3.9
3.5
1.52
1.90
mmol/l
0.60
130
948
55
258
2.16
6.59
1.4
1.4
152616.45
65720.25
e6/l
0.52
33
154
31
111
2.82
6.58
1.7
1.5
—
—
—
0
0
63
313
2.04
6.52
1.3
1.5
31.93
32.21
g/l
0.07
51
284
196
1344
1.50
6.43
3.9
3.6
5.01
5.15
kpa
1.55
179
1279
993
8709
1.26
6.34
2.7
2.3
—
—
—
0
0
36
143
2.54
6.28
2.0
2.3
—
—
—
0
0
89
504
1.80
6.25
1.6
1.6
0.84
12.61
iu/ml
0.52
12
107
1189
10659
1.25
6.22
3.9
3.2
60.72
54.93
u/l
1.12
1127
9722
545
6562
0.77
6.11
3.5
3.8
11.64
8.19
mg/mmol
1.07
348
4085
149
974
1.57
6.09
2.9
3.1
4.24
4.38
pmol/l
1.24
121
841
265
1948
1.41
6.05
3.8
3.4
5.74
5.84
kpa
0.82
254
1889
263
1939
1.40
5.90
3.8
3.4
1.68
2.06
mmol/l
0.88
214
1619
81
455
1.81
5.86
2.8
2.5
15.25
15.91
%
0.58
45
227
404
3196
1.32
5.78
3.1
3.1
1.60
2.27
e6/l
1.73
209
1796
15
27
5.59
5.68
14.9
3.5
—
—
—
0
0
482
3919
1.29
5.63
3.9
3.1
2.45
2.46
mmol/l
1.53
431
3443
717
6124
1.25
5.58
2.3
2.2
145.28
223.01
u/l
3.44
671
5720
528
6321
0.78
5.53
3.0
3.2
6.90
7.16
mmol/l
0.60
439
5226
29
111
2.63
5.48
1.7
1.5
—
—
—
0
0
216
1563
1.42
5.39
4.2
2.9
57.05
61.22
ml/min/173m2
1.33
138
648
32
130
2.48
5.37
1.7
1.5
—
—
—
0
0
24
85
2.84
5.25
1.4
5.4
—
74.94
—
0
18
79
457
1.76
5.22
1.7
1.6
—
—
—
0
0
521
6212
0.79
5.21
3.2
3.3
1525.03
251.29
mg/l
2.71
334
3926
74
425
1.77
5.02
2.2
1.4
—
—
—
0
0
77
450
1.74
4.93
1.5
1.3
—
—
—
0
0
77
450
1.74
4.93
1.5
1.3
—
—
—
0
0
1750
16577
1.27
4.90
5.2
4.3
1.32
1.29
mmol/l
0.56
1644
14786
27
106
2.57
4.88
4.0
1.8
—
—
—
0
0
112
728
1.57
4.75
3.0
2.2
237.74
871.69
ug/l
1.50
106
687
130
877
1.51
4.67
4.9
5.5
1.80
1.58
%
1.56
120
825
573
4858
1.24
4.62
4.4
4.4
0.00
0.00
estimate
0.69
269
1593
48
250
1.94
4.46
2.6
1.4
—
—
—
0
0
48
250
1.94
4.46
2.6
1.4
—
—
—
0
0
48
252
1.92
4.36
2.6
1.4
—
—
—
0
0
48
252
1.92
4.36
2.6
1.4
—
—
—
0
0
127
866
1.50
4.35
5.0
5.6
0.90
0.89
%
0.11
117
816
48
253
1.92
4.31
2.6
1.4
—
—
—
0
0
12
24
5.02
4.31
1.0
1.9
—
—
—
0
0
253
1951
1.34
4.30
1.9
2.1
0.20
0.21
g/l
1.31
230
1820
26
108
2.42
4.22
3.5
3.7
—
—
—
0
0
48
255
1.90
4.22
2.6
1.4
—
—
—
0
0
15
46
3.28
4.19
1.1
1.3
—
—
—
0
0
112
752
1.52
4.15
1.8
1.8
40.06
38.75
u/l
0.23
94
651
166
1209
1.40
4.04
1.5
1.5
—
—
—
0
0
411
3408
1.25
3.99
3.1
2.9
1.27
1.27
e6/l
0.01
220
2000
1429
13356
1.20
3.98
4.3
4.0
15.17
15.02
pmol/l
1.38
1302
11883
305
2448
1.29
3.87
7.4
7.2
12.21
11.94
kpa
0.29
291
2333
305
2448
1.29
3.87
7.4
7.2
4.90
5.09
kpa
3.16
291
2333
11
23
4.80
3.87
1.6
1.4
—
—
—
0
0
228
1763
1.33
3.81
2.3
2.4
32.48
39.47
u/l
1.35
201
1507
852
7628
1.19
3.80
2.3
2.2
78.69
78.98
nmol/l
0.11
764
6664
1931
18646
1.30
3.80
34.7
19.4
139.48
139.66
mmol/l
2.39
1911
18151
6
5
12.03
3.76
3.2
1.0
—
—
—
0
0
275
2190
1.29
3.71
7.8
7.5
95.62
95.43
%
0.21
266
2111
1755
16771
1.23
3.71
33.1
15.6
74.16
74.72
ml/min/173m2
0.59
1570
13949
302
2448
1.27
3.55
7.5
7.2
0.92
1.18
mmol/l
0.46
232
1933
75
480
1.58
3.48
3.1
2.9
7.69
7.92
kpa
0.73
75
468
1931
18689
1.28
3.41
37.4
19.6
4.02
3.99
mmol/l
6.87
1908
18163
56
905
0.61
3.39
2.0
1.8
—
—
—
0
0
32
161
2.00
3.35
1.2
1.1
—
—
—
0
0
42
232
1.83
3.34
1.5
1.4
—
—
—
0
0
152
1135
1.36
3.23
8.8
10.1
—
—
—
0
0
84
564
1.51
3.18
1.9
1.7
—
—
—
0
0
115
822
1.42
3.17
4.4
3.9
24.34
24.83
mmol/l
0.88
101
758
6
8
7.52
3.05
1.2
1.0
—
—
—
0
0
9
21
4.30
2.99
1.3
1.2
—
—
—
0
0
1926
18686
1.25
2.97
29.8
11.3
24.00
25.29
u/l
4.35
1899
17906
6
9
6.68
2.87
1.0
1.3
—
—
—
0
0
744
6708
1.17
2.86
4.3
4.3
—
—
—
0
0
247
2010
1.26
2.83
8.3
8.0
114.81
120.52
g/l
3.59
240
1958
108
782
1.40
2.80
2.1
3.3
14.00
5323.03
u/ml
0.88
91
669
201
1598
1.28
2.79
3.3
2.8
4.33
4.55
kpa
0.94
194
1545
18
78
2.32
2.74
1.6
1.3
—
—
—
0
0
11
34
3.25
2.72
1.2
1.1
—
—
—
0
0
54
341
1.60
2.72
1.6
1.5
359.91
292.62
pmol/l
0.26
54
335
37
212
1.76
2.67
1.1
1.3
270.00
276.65
mosm/kgh2o
1.19
30
152
75
513
1.48
2.65
1.3
1.7
—
—
—
0
0
11
35
3.15
2.64
1.7
1.5
—
—
—
0
0
73
499
1.48
2.59
1.3
1.2
—
—
—
0
0
1688
16233
1.17
2.55
5.4
4.9
2.09
2.09
mu/l
0.03
1584
14541
239
1963
1.24
2.54
3.4
2.9
206.13
221.59
ng/l
0.27
223
1790
68
461
1.49
2.52
2.7
2.1
123.14
128.00
g/l
0.69
57
333
38
225
1.70
2.47
2.6
3.9
—
—
—
0
0
259
2154
1.23
2.46
4.4
3.6
—
—
—
0
0
20
96
2.09
2.43
1.0
1.0
—
—
—
0
0
73
507
1.45
2.42
1.3
1.1
—
—
—
0
0
1772
17137
1.18
2.36
5.7
4.8
1.31
1.46
mmol/l
40.92
1676
15439
7
17
4.13
2.36
1.4
1.1
—
—
—
0
0
27
148
1.83
2.28
1.2
1.1
—
—
—
0
0
1786
17296
1.18
2.28
5.7
4.8
4.14
4.54
mmol/l
48.95
1695
15711
45
286
1.59
2.26
1.2
1.1
—
—
—
0
0
7
18
3.90
2.25
1.0
1.2
—
—
—
0
0
24
131
1.84
2.08
1.1
1.1
—
—
—
0
0
5
10
5.01
2.07
2.8
4.9
—
—
—
0
0
19
96
1.99
2.05
1.2
1.4
—
—
—
0
0
39
246
1.60
2.04
1.2
1.2
217.67
194.21
miu/ml
0.12
12
87
16
76
2.11
2.02
1.3
2.0
4114.00
25665.76
e6/l
0.45
11
45
67
477
1.42
1.99
6.6
7.6
104.81
105.38
mmol/l
0.50
59
431
53
362
1.48
1.96
1.3
1.4
—
—
—
0
0
11
45
2.45
1.93
2.5
1.7
1.21
1.36
ug/l
0.14
11
40
192
1594
1.22
1.90
3.0
3.7
85.74
92.71
ng/l
0.66
169
1357
16
79
2.03
1.85
1.2
1.1
—
—
—
0
0
22
122
1.81
1.84
1.2
1.1
—
—
—
0
0
22
122
1.81
1.84
1.2
1.1
—
—
—
0
0
31
192
1.62
1.78
1.1
1.1
—
—
—
0
0
8
30
2.67
1.72
1.9
1.2
—
—
—
0
0
22
125
1.77
1.72
1.2
1.1
—
—
—
0
0
22
125
1.77
1.72
1.2
1.1
—
—
—
0
0
22
125
1.77
1.72
1.2
1.1
—
—
—
0
0
18
96
1.88
1.70
1.3
1.1
—
—
—
0
0
6
19
3.16
1.66
1.5
1.1
—
—
—
0
0
6
19
3.16
1.66
1.0
1.5
—
—
—
0
0
65
478
1.37
1.65
3.3
3.2
1.33
1.62
mmol/l
3.30
60
468
49
343
1.44
1.64
1.7
1.9
4.58
4.84
mmol/24h
0.21
44
288
208
1769
1.19
1.63
2.1
2.1
255.72
150.70
ug/g
1.47
159
1397
61
445
1.38
1.63
1.1
1.2
5.04
7.32
u/ml
—
5
72
161
1336
1.22
1.63
7.1
7.0
24.07
24.52
mmol/l
0.97
151
1273
16
84
1.91
1.59
1.3
2.1
977.00
840.42
e6/l
0.14
11
66
10
43
2.33
1.58
1.1
1.3
—
—
—
0
0
55
397
1.40
1.57
1.3
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
107
1.78
1.54
1.2
1.1
—
—
—
0
0
15
78
1.93
1.54
36.1
25.6
134.60
117.95
ug/l
0.50
15
63
18
100
1.81
1.53
1.3
1.6
6.19
8.10
u/l
0.47
13
85
365
4063
0.88
1.49
2.9
3.2
0.76
0.78
ug/l
0.10
254
2856
18
101
1.79
1.49
1.1
1.1
—
—
—
0
0
257
2250
1.16
1.45
2.7
4.1
22.46
20.92
ug/l
0.05
206
1877
10
46
2.18
1.40
1.1
1.3
—
—
—
0
0
9
179
0.50
1.39
1.3
1.2
1.35
1.39
nmol/l
—
9
159
51
374
1.37
1.36
1.2
1.1
—
—
—
0
0
6
24
2.50
1.30
1.3
1.3
—
—
—
0
0
6
25
2.40
1.24
1.0
1.2
—
—
—
0
0
8
37
2.17
1.21
1.0
1.2
—
—
—
0
0
53
401
1.33
1.19
1.2
1.1
0.78
6.82
u/ml
—
5
29
40
290
1.39
1.17
1.1
1.1
—
—
—
0
0
155
1330
1.18
1.16
9.8
8.8
93.72
93.81
%
0.06
155
1322
27
183
1.48
1.13
1.2
1.3
—
—
—
0
0
26
175
1.49
1.13
1.2
1.3
—
—
—
0
0
529
5674
0.91
1.11
4.0
4.6
21.53
21.70
%
0.09
258
2954
13
73
1.79
1.10
1.1
1.4
129.46
165.64
mmol/24h
1.44
13
73
84
685
1.24
1.08
1.4
1.2
—
—
—
0
0
33
451
0.73
1.03
5.6
3.7
36.79
28.41
mg/l
0.51
21
278
36
265
1.36
1.00
1.3
1.3
15.93
10.38
u/l
1.43
28
212
214
1908
1.13
0.99
1.4
1.3
—
—
—
0
0
5
23
2.18
0.98
1.8
1.0
—
—
—
0
0
139
1600
0.86
0.97
1.5
1.7
1.51
1.56
%
0.46
112
1327
6
27
2.23
0.93
1.0
1.0
—
—
—
0
0
35
260
1.35
0.93
1.3
1.3
36.77
32.50
iu/l
0.35
29
220
37
485
0.76
0.90
1.3
1.7
5548.19
13685.29
e6/l
3.24
26
346
16
102
1.57
0.90
2.2
2.4
—
—
—
0
0
6
29
2.07
0.89
1.5
1.0
—
—
—
0
0
1804
17742
1.09
0.89
6.3
5.4
2.36
2.63
mmol/l
35.54
1710
16012
14
87
1.61
0.87
3.1
1.5
12.69
11.11
ug/l
0.12
14
76
6
31
1.94
0.84
1.3
1.2
—
—
—
0
0
8
45
1.78
0.84
1.0
1.1
—
—
—
0
0
61
499
1.23
0.81
1.3
1.2
—
—
—
0
0
363
3902
0.92
0.81
4.4
4.4
1.02
1.02
kg/l
0.10
48
590
6
33
1.82
0.79
1.3
1.2
—
—
—
0
0
673
7052
0.93
0.78
4.9
5.3
4.91
3.85
ug/l
0.35
585
6238
64
535
1.20
0.71
2.8
3.2
0.79
0.82
nmol/l
0.25
48
421
7
40
1.75
0.71
1.1
1.1
—
6.68
—
0
5
9
57
1.58
0.71
1.0
1.1
—
—
—
0
0
5
26
1.93
0.70
1.2
1.1
—
—
—
0
0
9
58
1.55
0.69
1.3
1.1
—
—
—
0
0
9
58
1.55
0.69
1.0
2.1
21.37
157.37
ug/l
—
9
50
9
59
1.53
0.68
1.3
1.1
—
—
—
0
0
1769
17441
1.07
0.66
5.3
5.1
5.94
6.07
mmol/l
4.92
1624
15585
31
393
0.79
0.64
1.4
1.4
—
—
—
0
0
117
1042
1.13
0.61
3.6
3.1
24.63
25.34
mmol/l
1.25
110
1008
8
50
1.60
0.61
1.0
1.3
8.26
9.15
ug/l
—
8
50
0
20
0.00
0.60
0.0
1.1
—
8.59
—
0
20
27
209
1.30
0.60
1.0
1.1
—
16.90
—
0
8
31
388
0.80
0.59
1.4
1.4
0.98
0.82
nmol/l
0.64
26
311
142
1291
1.11
0.54
3.3
3.0
121.32
127.82
g/l
2.38
133
1257
34
276
1.24
0.54
1.6
1.9
176.03
205.77
pmol/l
0.74
34
259
11
74
1.49
0.53
1.6
1.5
—
—
—
0
0
416
4368
0.94
0.52
1.6
1.7
31845756.54
23505063.46
pmol/l
0.10
336
3561
9
64
1.41
0.51
1.3
1.1
—
—
—
0
0
513
4923
1.05
0.49
1.7
1.7
1.50
1.35
mmol/l
1.48
449
4056
66
578
1.15
0.48
1.3
1.5
294.84
274.55
ug/g
0.43
37
346
360
3426
1.06
0.46
1.2
1.2
2.33
1.45
u/ml
0.23
48
870
1934
19181
1.07
0.46
56.9
24.3
39.11
39.60
%
2.75
1823
17699
5
31
1.61
0.43
1.0
1.2
—
—
—
0
0
1934
19191
1.07
0.42
57.1
24.2
9.40
6.79
e9/l
28.14
1906
18549
13
173
0.75
0.42
1.2
1.4
41.29
25.92
%
—
8
107
1934
19194
1.06
0.41
57.0
24.2
4.18
4.42
e12/l
33.96
1906
18551
8
59
1.36
0.41
1.4
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
1934
19197
1.06
0.40
57.4
24.3
128.31
133.65
g/l
38.30
1922
18847
49
428
1.15
0.39
1.6
2.7
32.88
34.67
umol/l
0.19
41
378
242
2555
0.94
0.39
9.4
7.6
—
—
—
0
0
1933
19191
1.06
0.39
57.2
24.2
379.30
242.94
e9/l
194.08
1912
18621
16
124
1.29
0.38
1.4
1.7
—
—
—
0
0
71
639
1.11
0.37
4.2
4.0
3.89
3.92
mmol/l
0.21
71
633
5
80
0.62
0.35
1.4
1.1
—
—
—
0
0
81
888
0.91
0.34
1.3
1.3
56.00
195.94
u/ml
9.58
67
816
95
1033
0.92
0.34
1.3
1.3
57.00
60.12
au/ml
—
5
58
48
539
0.89
0.32
1.2
1.4
—
—
—
0
0
87
945
0.92
0.31
1.2
1.2
113.42
135.80
iu/ml
0.28
28
342
13
101
1.29
0.31
1.1
1.5
0.93
0.96
g/l
0.08
13
101
19
156
1.22
0.31
1.0
1.1
—
55.14
—
0
14
107
1150
0.93
0.31
2.6
2.5
20.63
25.24
au/ml
—
9
56
65
714
0.91
0.30
1.0
1.0
—
—
—
0
0
13
102
1.28
0.30
1.1
1.0
—
—
—
0
0
42
373
1.13
0.29
1.9
1.7
—
—
—
0
0
8
65
1.23
0.27
1.4
1.1
—
—
—
0
0
12
150
0.80
0.27
1.1
1.1
0.19
1.71
u/ml
—
5
73
8
67
1.19
0.26
1.1
1.2
152.68
263.37
iu/ml
—
8
67
34
381
0.89
0.24
1.2
1.8
2.83
4.85
iu/l
1.54
11
116
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
17
144
1.18
0.22
1.0
1.1
—
5.17
—
0
6
0
10
0.00
0.21
0.0
1.3
—
2.60
—
0
10
209
2013
1.04
0.21
1.4
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
5
43
1.16
0.21
1.4
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
4059.29
—
0
7
0
14
0.00
0.20
0.0
1.8
—
15.44
—
0
9
0
14
0.00
0.20
0.0
1.5
—
23.67
—
0
6
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
9
111
0.81
0.20
1.3
1.6
104.44
88.67
umol/l
—
9
111
20
174
1.15
0.19
2.1
2.2
582.40
618.53
ml
—
10
110
5
69
0.72
0.17
1.6
1.3
—
—
—
0
0
12
101
1.19
0.16
1.3
1.4
1.37
1.06
nmol/l
—
7
77
19
168
1.13
0.15
1.3
1.0
3.18
2.15
u/ml
—
6
53
10
83
1.21
0.15
1.0
1.2
—
—
—
0
0
11
93
1.18
0.14
1.2
1.5
0.27
0.21
nmol/l
—
6
68
187
1924
0.97
0.14
2.3
2.5
4.74
7.40
ug/l
2.71
150
1677
49
521
0.94
0.14
2.6
2.1
109.97
88.10
ug/min
0.24
27
304
125
1210
1.04
0.12
2.2
2.2
12.58
12.63
nmol/l
0.02
106
1057
17
154
1.10
0.10
2.2
1.4
—
—
—
0
0
257
2525
1.02
0.10
5.1
4.8
31.81
33.29
%
1.55
194
1637
29
310
0.93
0.10
1.3
1.4
—
—
—
0
0
5
45
1.11
0.09
2.8
2.8
14.78
14.73
ml/dl
—
5
40
6
54
1.11
0.09
1.0
1.1
1914.83
1561.94
miu/ml
—
6
54
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
21
195
1.08
0.08
2.0
1.5
—
—
—
0
0
6
75
0.80
0.07
1.0
1.0
—
—
—
0
0
22
235
0.94
0.07
1.3
1.6
64.60
63.99
%
0.03
15
147
286
2824
1.01
0.07
1.2
1.2
35.29
39.34
iu/ml
0.22
100
913
9
85
1.06
0.07
1.7
1.3
192.96
164.91
pmol/l
—
9
85
48
462
1.04
0.07
1.9
3.4
854.52
916.98
u/ml
0.03
41
428
107
1047
1.02
0.06
2.5
2.8
0.33
0.34
e6/l
0.02
102
1021
1683
16792
1.01
0.06
6.1
6.4
37.55
40.74
mmol/mol
47.91
1591
15270
10
90
1.11
0.05
1.9
1.2
294.20
398.87
u/l
—
10
84
61
594
1.03
0.05
1.4
1.6
—
—
—
0
0
11
102
1.08
0.03
5.7
3.4
13.86
13.25
%
0.89
11
102
12
113
1.06
0.01
1.4
1.2
0.56
1.30
u/ml
—
6
61
16
153
1.05
0.01
1.1
1.1
—
—
—
0
0
22
227
0.97
0.01
1.5
1.5
—
—
—
0
0
274
2732
1.00
0.01
1.2
1.2
13.59
13.51
u/ml
0.01
83
974
11
104
1.06
0.01
1.0
1.0
—
—
—
0
0
10
106
0.94
0.01
1.7
1.1
—
—
—
0
0
39
384
1.02
0.00
1.2
1.3
17.90
35.39
e6/l
0.43
31
293
39
384
1.02
0.00
1.3
1.3
1873.75
742.93
e6/l
0.39
32
310
10
105
0.95
0.00
1.7
1.1
—
—
—
0
0
11
112
0.98
0.00
1.1
1.2
9.59
10.02
mmol/l
0.16
11
106
17
168
1.01
0.00
2.0
2.1
3.80
1.91
u/field
—
10
56
53
533
0.99
0.00
1.3
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
7.74
—
0
8
6
65
0.92
-0.00
4.8
2.4
—
—
—
0
0
6
65
0.92
-0.00
4.8
2.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
1.1
1.4
1.37
1.57
g/l
—
7
73
0
5
0.00
-0.00
0.0
8.0
—
74.80
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_L01XX – L01XX Other antineoplastic agents
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).